News
The Chanhassen-based company plans to use the funds on a randomized trial of its “sonodynamic therapy” for glioblastoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback